Effectiveness of Intravenous Levetiracetam as an Adjunctive Treatment in Pediatric Refractory Status Epilepticus

Abstract

The current study demonstrated that the adjunctive use of intravenous LEV was effective and well tolerated in pediatric patients with refractory SE, even in patients younger than 2 years. Intravenous LEV should be considered as an effective and safe treatment option for refractory SE in pediatric patients.